Fig. 1: Patient cohorts and survival outcomes.

A Schematic overview of polyostotic-DLBCL, PB-DLBCL and nodal-DLBCL-GCB patients and successfully performed targeted NGS and GEP panels. B Clinical course and median survival times per DLBCL subtype. C Comparison of the overall, progression-free and disease-specific survival of the three cohorts.